Síndrome do Intestino Irritável Online (Irritable bowel syndrome)

■ Updates to the Rome criteria for irritable bowel syndrome

Lin Chang

Gastroenterol Hepatol (N Y) 2017 May; 13(5): 304–306.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479345/

■ Guía de Práctica Clínica: síndrome del intestino irritable con estreñimiento y estreñimiento funcional en adultos

Mearin, Fermín et al

Rev. esp. enferm. dig., June 2016, vol.108, no.6, p.332-363

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082016000600007&lng=en&nrm=iso&tlng=es

■ What is new in Rome IV?

Max J Schmulson, Douglas A Drossman

J Neurogastroenterol Motil. 2017 Apr; 23(2): 151–163.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383110/

■ Biomarkers of irritable bowel syndrome

Jae Hak Kim, Eugenia Lin, Mark Pimentel

J Neurogastroenterol Motil. 2017 Jan; 23(1): 20–26

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216630/

■ Prevalence, risk factors, and outcomes of irritable bowes syndrome after infectious enteritis: a systematic review and meta-analysis

F Klem, A Wadhwa, L J Prokop et al

Gastroenterology 2017,vol 152 (5): 1042-1054

http://www.gastrojournal.org/article/S0016-5085(17)30008-2/fulltext

■ Assessing the sleep quality and depression-anxiety-stress in irritable bowel syndrome patients

Baniasadi, Nadieh et AL

Arq. Gastroenterol., June 2017, vol.54, no.2, p.163-166

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032017000200163&lng=en&nrm=iso&tlng=en

■ Calidad de vida relacionada con la salud en adultos con síndrome de intestino irritable en un hospital de especialidades de México: estudio transversal.

Sánchez-Cuén, Jaime Alberto et al

Rev. esp. enferm. dig., Apr 2017, vol.109, no.4, p.265-272

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082017000400005&lng=en&nrm=iso&tlng=es

■ Irritable bowel syndrome and nickel allergy: What is the role of the low nickel diet?

Angela Rizzi, Eleonora Nucera, Lucrezia Laterza et al

J Neurogastroenterol Motil. 2017 Jan; 23(1): 101–108

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216640/

■ Prevalence of irritable bowel syndrome and health-related quality of life in adults aged 18 to 30 years in a Colombian University: an electronic survey

Martín Cañón, Alvaro J. Ruiz, Martín Rondón, Jaime Alvarado

Ann Gastroenterol. 2017; 30(1): 67–75

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198249/

■ Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional study

Martin Aasbrenn, Ingvild Høgestøl, Inger Eribe et al

BMC Obes. 2017; 4: 22

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490229/

■ Systematic review: the placebo effect of psychological interventions in the treatment of irritable bowel syndrome

Carla E Flik, Laura Bakker, Wijnand Laan, Yanda R van Rood, André J P M Smout, Niek J de Wit

World J Gastroenterol. 2017 Mar 28; 23(12): 2223–2233

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374135/

■ Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice

Susan Lucak, Lin Chang, Albena Halpert, Lucinda A. Harris

Therap Adv Gastroenterol. 2017 , vol 10(2): 253–275

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298476/

■ Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study

Chloé Melchior, Moutaz Aziz, Typhaine Aubry et al

United European Gastroenterol J. 2017, vol 5(2): 261–269

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349360/

■ Irritable bowel syndrome: clinical manifestations, dietary influences and management

Ronald Ikechi, Bradford D. Fischer, Joshua DeSipio, Sangita Phadtare

Healthcare (Basel) 2017, vol 5(2): 21

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492024/

■ Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients

Anamaria Cozma-Petruţ, Felicia Loghin, Doina Miere, Dan Lucian Dumitraşcu

World J Gastroenterol. 2017, vol 23(21): 3771–378

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467063/

■ Dietary fiber in irritable bowel syndrome (review)

Magdy El-Salhy, Synne Otterasen Ystad, Tarek Mazzawi, Doris Gundersen

Int J Mol Med. 2017, vol 40(3): 607–613

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548066/

■ Association between self-reported vegetarian diet and the irritable bowel syndrome in the French NutriNet cohort

Camille Buscail, Jean-Marc Sabate, Michel Bouchoucha, Marion J. Torres, Benjamin Allès, Serge Hercberg, Robert Benamouzig, Chantal Julia

PLoS One. 2017; vol 12(8): e0183039

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571937/

■ Irritable bowel syndrome and diet

Piero Portincasa, Leonilde Bonfrate, Ornella de Bari et al

Gastroenterol Rep (Oxf) 2017, vol 5(1): 11–1

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444258/

■ Dietary triggers in irritable bowel syndrome: Is there a role for glúten?

Umberto Volta, Maria Ines Pinto-Sanchez, Elisa Boschetti,et al

J Neurogastroenterol Motil. 2016 Oct; 22(4): 547–557

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056565/

■ The combination of oligo-and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: results of a randomized, placebo-controlled, double-blind, parallel group, multicentre clinical trial

Octavian Alexea, Vlad Bacarea, Núria Piqué

United European Gastroenterol J. 2016 Jun; 4(3): 455–465

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924437/

■ Comparison of symptoms, healthcare utilization, and treatment in diagnosed and undiagnoses individuals with diarrhea-predominant irritable bowel syndrome

Gregory S Sayuk, Ray Wolf, Lin Chang

Am J Gastroenterol. 2017,vol 112(6): 892–89

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465427/

■ Cognitive-behavioral therapy for patients with irritable bowel syndrome: currents insights

Sarah W Kinsinger

Psychol Res Behav Manag. 2017; vol 10: 231–237.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530860/

■ Psychological interventions for irritable bowel syndrome and inflammatory bowel disease

Sarah Ballou, Laurie Keefer

Clin Transl Gastroenterol. 2017 , vol 8(1): e214

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288603/

■ Sympton burden and consulting behavior in patients with overlapping functional disorders in the US population

Nimish Vakil, Margie Stelwagon, Elizabeth P Shea, Steve Miller

United European Gastroenterol J. 2016 Jun; 4(3): 413–422

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924424/

■ Systematic review: the placebo effect of psychological interventions in the treatment of irritable bowel syndrome

Carla E Flik, Laura Bakker, Wijnand Laan, Yanda R van Rood, André J P M Smout, Niek J de Wit

World J Gastroenterol. 2017, vol 23(12): 2223–2233

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374135/

■ Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea

Jessica L. Buono, Robyn T. Carson, Natalia M. Flores

Health Qual Life Outcomes. 2017; vol 15: 35

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310011/

■ High risk of temperomandibular disorder in irritable bowel syndrome: Is there a correlation with greater illness severity?

Serena Gallotta, Vincenzo Bruno, Santo Catapano, et al

World J Gastroenterol. 2017 Jan 7; 23(1): 103–109

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221272/

■ Acupuncture for irritable bowel syndrome: 2-year follow-up of a randomized controlled trial

H MacPherson, H Tilbrook, D Agbedjro et al

Acupunct Med. 2017, vol 35(1): 17–23

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466911/

■ Targeting histamine receptors in irritable bowel syndrome: a critical appraisal

Adam Fabisiak, Jakub Włodarczyk, Natalia Fabisiak et AL

J Neurogastroenterol Motil. 2017 Jul; 23(3): 341–348

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503283/

■ Neuroendocrine dysregulation in irritable bowel syndrome patients: a pilot study

Cristina Stasi, Massimo Bellini, Dario Gambaccini, et AL

J Neurogastroenterol Motil. 2017 Jul; 23(3): 428–434

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503293/

■ Effects of cognitive behavior therapy on heart rate variability in young females with constipation-predominant irritable bowel syndrome: a parallel-group trial

Aelee Jang, Sun-Kyung Hwang, Nikhil S Padhye, Janet C Meininger

J Neurogastroenterol Motil. 2017 Jul; 23(3): 435–445

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503294/

■ Maturation phenotype of peripheral blood monocyte/macrophage after stimulation with lipopolysaccharides in irritable bowel syndrome

riggers in irritable bowel syndrome: Is ther a role for gluten?

Oscar A Rodríguez-Fandiño, Joselín Hernández-Ruiz, Yolanda López-Vidal et al

J Neurogastroenterol Motil. 2017 Apr; 23(2): 281–288

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383123/

■ Balance of autonomic nervous system predicts who benefits from a self-management intervention program for irritable bowel syndrome

Monica E Jarrett, Kevin C Cain, Pamela G Barney et al

J Neurogastroenterol Motil. 2016 Jan; 22(1): 102–11

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699727/

■ Post-infectious irritable bowel syndrome (PI-IBS) after infection with Shiga-like toxin-producing Escherichia coli (STEC) O104: H4: a cohort study with prospective follow-up

Viola Andresen, Bernd Löwe, Wiebke Broicher et al

United European Gastroenterol J. 2016 Feb; 4(1): 121–13

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766540/

■ Visceral pain perception in patients with irritable syndrome and healthy volunteers is affected by the MRI scanner environment

Reuben K Wong, Lukas Van Oudenhove, Xinhua Li,et al

United European Gastroenterol J. 2016 Feb; 4(1): 132–141

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766539/

■ Update on irritable bowel syndrome diagnostics and therapeutics

Mark Pimentel

Gastroenterol Hepatol (N Y) 2016 Jul; 12(7): 442–445.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969781/

■ Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage

Evangelos J. Giamarellos-Bourboulis, Emmanouel Pyleris, Charalambos Barbatzas, Aikaterini Pistiki, Mark Pimentel

BMC Gastroenterol. 2016; 16: 67

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940948/

■ Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowe syndrome in a clinical study population

Leticia Delgado-Herrera, Kathryn Lasch, Bernhardt Zeiher et al

Therap Adv Gastroenterol. 2017 , vol 10(9): 673–68

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598814/

■ Cytokine and anti-cytokine therapies in preventionor treatment in fibrosis in IBD

Noam Jacob, Stephan R Targan, David Q Shih

United European Gastroenterol J. 2016 Aug; 4(4): 531–540

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971798/

■ Parasitosis y síndrome de intestino irritable.

Ibarra, Catalina et al.

Rev. chil. infectol., Jun 2016, vol.33, no.3, p.268-274

http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182016000300003&lng=en&nrm=iso

■ Irritable bowel syndrome subtypes: clinical and psychological features, body mass index and comorbidities